Pro Medicus, Ltd. · ASX:PME

Pro Medicus — FY2024 Earnings Presentation

38 slides from Pro Medicus's earnings presentation, Aug 14, 2024

  1. Slide 1: FY24 Full Year results

    FY24 Full Year results August 2024

  2. Slide 2: Pro Medicus (ASX:PME)

    PRO MEDICUS (ASX:PME) Healthcare IT company specializing in Enterprise Imaging and Radiology Information System (RIS) software. Leading edge products, growing global presence. EU HQ/R&D Berlin GmbH U.S. HQ San Diego CA GROUP HQ Melbourne AUS OVER 40+ SOFTWARE ENGINEERS 2

  3. Slide 3: Results FY 2024

    RESULTS FY 2024 $161.5M $82.8M $112.3M 69.5% Revenue Profit Underlying EBIT up 29.3% after tax EBIT margins up 36.5% up 33.8% $155.4M $0.22 Cash Company Strong Final & debt balance dividend FF Investments free sheet Up 33.3% up 27.9%

  4. Slide 4: FY 2024 – Results

    FY 2024 – Results • Record year • Nine contract wins in North America • Completed nine cloud-based implementations • RSNA 2023 the busiest to date • Progress with other ologies and AI • Forms base for growth in FY25 and beyond 4

  5. Slide 5: Highlights FY 2024

    HIGHLIGHTS FY 2024 $24M/7 years $140M/10 years $16M/8 years $20M/8 years $9.5M/5 years $11.5M/7 years New Contract New Contract New Contract New Contract New Contract New Contract JULY SEPTEMBER OCTOBER NOVEMBER JANUARY 2024 APRIL 2024 2023 2023 2023 2023

  6. Slide 6: Highlights FY 2024

    HIGHLIGHTS FY 2024 $6.5M/5 years $9M/8 years $8.5M/5 years Continues to grow New Contract New Contract New Contract STRONGLY APRIL 2024 MAY 2024 MAY 2024 NOVEMBER - NINE CURRENT DECEMBER IMPLEMENTATIONS PIPELINE 2023 FY2024 6

  7. Slide 7: FY 2024 Revenue Split

    A Ad FY 2024 REVENUE SPLIT $180,000,000 GExam/licence revenue*** CSupport/baseline revenue*** O Professional Services*** D Archive data migration ***Recurring revenue $160,000,000 y $9,954,000 $140,000,000 2,059,000 $120,000,000 Vy $100,000,000 A $80,000,000 N $60,000,000 $6,047,000 | $40,000,000 A

  8. Slide 8: Operating Leverage

    OPERATING LEVERAGE • Highly scalable offering • No capex (HW) – SW only model • Training & Installation – charged as professional services • Highly contained cost base • Margin continues to grow as footprint increases 8

  9. Slide 9: Operational (Transaction) Model

    OPERATONAL (TRANSACTION) MODEL • Used in vast majority of US contracts • Delivered as SaaS model • Now used in RIS contracts in AUS • Model based on transaction minimums • Forward revenue > A$624M/5 years* • Upside as client examination volumes grow • Annuity style revenue stream – greater predictab

  10. Slide 10: In Review | 2024/2025 Top Hospitals

    In Review | 2024/2025 Top Hospitals (alphabetical order) Source: U.S. News & World Rep ort Top 20 Hospitals 2024-2025 10

  11. Slide 11: Increasing footprint in the IDN space

    Increasing footprint in the IDN space • IDNs represent the largest segment of the market • IDN clients across broad spread of opportunities from large multi-state to smaller regional • Most recent IDN sales for more than one Visage product – many “full stack”. • All recent IDN opportunities Cloud de

  12. Slide 12: Visage RIS

    @VISAGERIS TECHNOLOGIST DOCTOR TRANSCRIPTIONIST SEARCH OFFICE CLAIMING SETUP. Recent|* Dr R Simps Appointments Resin “Northern Bock Visage General Hospital 4 Tue, 17-0c02017 > "BR TA) ST TAMTTFI @ Patient @ Procedure MF Cancelled | Blocked Visage Xray + a Visage CT + Visage US Room1 + rsn_| Visage U

  13. Slide 13: Visage RIS

    VISAGE RIS • Long term (5 year) contracts with Lumus (Primary Healthcare) and I–MED, the 2 biggest radiology providers in AUS • Upside via organic and M&A growth (I-MED) • Increased market interest – new opportunities • PME undisputed market leader

  14. Slide 14: Visage 7.0

    Visage 7.0 Continues to be #1 in Speed, Functionality and Scalability. SPEED FUNCTIONALITY SCALABILITY

  15. Slide 15: Massive Data Explosion

    MASSIVE DATA EXPLOSION • High density Multi-slice CT - 10,000+ images • HD Breast Tomosynthesis - 6 GB+ • Optoacoustic breast ultrasound - 10+ GB • Total Body PET Scan - 10+ GB • 7T MRI - much larger than 3T

  16. Slide 16: Legacy Technology

    LEGACY TECHNOLOGY “Compress and Send” MODALITIES PACS RADIOLOGIST/CLINICIAN

  17. Slide 17: Visage Solution: Streaming Technology

    Visage SOLUTION: VISAGE 7 Streaming Technology BACKEND RENDER SERVER SERVER RADIOLOGIST/CLINICIAN MODALITIES

  18. Slide 18: Fast Track Implementation

    FAST TRACK IMPLEMENTATION • All implementations on or ahead of schedule • Fast track methodology continues to deliver • Large scale projects completed well under 1/4 the time of industry norm • Delivers huge savings for client • Frees PME staff for other jobs • Reduces barrier to change • New highly

  19. Slide 19: Visage – Proven ROI

    VISAGE – PROVEN ROI Significant IT & Unparalleled Greater Clinical Infrastructure Increase in Accuracy Savings Radiologist Efficiency Improved Physician Delivers Superior Engagement Value Proposition 19

  20. Slide 20: Burnout – the new epidemic?

    Burnout – the new epidemic ? • Acute worldwide shortage of radiologists • Reduced intake of radiology residents over last few years – fears AI would take over • Larger datasets – more images to look at • Work life balance post COVID – work from home part of the mix • Many groups struggling to handle

  21. Slide 21: prosmedicus %

    prosmedicus % sare Visace Tuacine:

  22. Slide 22: Clinical Outcomes

    Clinical Outcomes Moving the Needle 22

  23. Slide 23: Growth Strategy

    GROWTH STRATEGY New product offerings – Transaction growth V7OA, worklist Extend to new from existing clients geographical markets Leverage R&D capability to Expand footprint introduce next – new clients generation products 23

  24. Slide 24: North America – TAM

    NORTH AMERICA – TAM • 650 Million exams performed per annum in the US • Growing by ~ 3.5% per year • Visage able to address 100% of TAM from a product perspective • ~ 85% of TAM addressable from commercial perspective – “full stack”, Cloud etc • Current penetration is 7% and growing • Very large add

  25. Slide 25: North American Pipeline

    NORTH AMERICAN PIPELINE Prospects Progressing Network Effect through various stages of the cycle Opportunities Increasing due to recent high-profile wins in both Tier 1 academic and IDN Increased number markets Pipeline Robust of inbound RFPs across all market segments In terms of quality and quanti

  26. Slide 26: Visage 7 Open Archive

    VISAGE 7 OPEN ARCHIVE • Same highly scalable Visage 7 platform • Visage 7 Open Archive integral part of “Full Stack” solution • Pipeline includes numerous Visage 7 Open Archive opportunities • Key component of Visage in the Cloud strategy • Transaction based model with potential upside 26

  27. Slide 27: Visage 7 Workflow

    VISAGE 7 WORKFLOW • Adds to Visage 7 Viewer and Open Archive modules • Based on over 30 years experience in Worklist SW • Allows PME to offer “full stack” solution • Integral part of Visage in the Cloud SaaS solution • Ability to interface with broad range of AI algorithms • Sold in majority of rece

  28. Slide 28: Visage CloudPACS

    Visage CloudPACS • Visage 7 – fully Cloud native • Ultrafast performance • Full Visage 7 functionality + security and scale of cloud • Cloud vendor agnostic - large scale implementations in all 3 cloud vendors - AWS, Azure and Google GCP • Pipeline mandating Cloud deployment • Significant strategic

  29. Slide 29: One Viewer - Cardiology

    One Viewer - Cardiology VISAGE TMAGING* Platform For The Future — Powered By Speed. prosmedicus of VisaGe IMAGING"

  30. Slide 30: AI in Radiology

    AI in Radiology • Imbedded in SW or imaging equipment • Prioritisation of cases – eg intracranial haemorrhage • Screening – eg early-stage lung nodule detection • Aid to diagnosis – 2nd opinion, incidental findings • Automated diagnosis 30

  31. Slide 31: AI Research Leadership

    AI Research Leadership Malte Westerhoff, PhD Global Chief Technology Officer Detlev Stalling, PhD Head of Development Ming De Lin, PhD Clinical Research Manager North America 31

  32. Slide 32: AI – Breast Density

    AI – Breast Density American Roentgen Ray Society (ARRS) The researchers found that the AI model showed extremely good agreement with the radiologists at 99.3%. 32

  33. Slide 33: Visage 7 Eco System

    Visage 7 Eco System ALL PHYSICIANS & CLINICIANS (Any Location*) O} ONE VIEWER™ FOR ALL ®_ Radiology @ cardiology | eS VISAGE 7® Ultra-Fast, Smart-Client, On-Demand Streaming <9 ALL MODALITIES. ALL LOCATIONS. VISAGE* 7 RESEARCH SERVER (3p VISAGE’ & OPEN ARCHIVE % VisAGe IMAGING:

  34. Slide 34: Visage Ease VP for Apple Vision Pro

    Visage Ease VP for Apple Vision Pro “From the Flintstones to the Jetsons” 34

  35. Slide 35: Visage Ease VP for Apple Vision Pro

    Visage Ease VP for Apple Vision Pro • Launched 5th February with launch of Apple Vision Pro • Visage’s cinematic rendering engine natively embedded in Visage Ease VP • Supports virtual screens at more than 4K resolution for each eye • Immersive, spatial experiences for diagnostic imaging and multime

  36. Slide 36: Visage Ease VP for Apple Vision Pro

    Visage Ease VP for Apple Vision Pro “Underpins our belief that our technology is 18 to 24 months ahead of competitors, if not more” 36

  37. Slide 37: Summary

    SUMMARY • Most successful year in company’s history • North American footprint continues to grow strongly • Expanded product portfolio – “full stack” solution • Cloud – huge strategic advantage over competitors • Unparalleled value proposition both clinical and financial RoI • Pipeline Continues to

  38. Slide 38: Thank You

    =) O = =< = <= < =

Pro Medicus — FY2024 Earnings Presentation on 6ix